Brief: Palisade Bio Is Granted Fast Track Designation From The U.S. Food And Drug Administration For LB1148 For Accelerated Return Of Bowel Function Following GI Surgery
Nov 22 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO IS GRANTED FAST TRACK DESIGNATION FROM THE
U.S.
FOOD AND DRUG ADMINISTRATION FOR LB1148 FOR ACCELERATED RETURN
OF BOWEL FUNCTION FOLLOWING GI SURGERY
Source text for Eikon: ID:nGNX7sLT63
Further company coverage: PALI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing